Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarmo T Laitinen

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitorsSusanna M Saario, Jarmo T Laitinen
Cellular and Molecular Neurobiology|June 5, 2004
Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retinaJuha R Savinainen, Jarmo T Laitinen
Journal of Pineal Research|September 7, 2007
Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulationTarja Kokkola, Maija Vaittinen, Jarmo T Laitinen
British Journal of Pharmacology|January 18, 2006
The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sectionsVille A B Palomäki, Jarmo T Laitinen
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 13, 2010
Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometryNiina Aaltonen, Jarmo T Laitinen, Marko Lehtonen
British Journal of Pharmacology|January 13, 2006
The 'allosteric modulator' SCH-202676 disrupts G protein-coupled receptor function via sulphydryl-sensitive mechanismsAnna M Lewandowicz, Jouko Vepsäläinen, Jarmo T Laitinen
Neuropharmacology|June 20, 2003
2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12Kati S Vasiljev, Asko Uri, Jarmo T Laitinen
Journal of Radiation Research|October 8, 2005
Exposure to a 50-hz magnetic field induces a circadian rhythm in 6-hydroxymelatonin sulfate excretion in miceTimo Kumlin, Päivi Heikkinen, Jarmo T Laitinen, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD6Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD12Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitorsSusanna M Saario, Jarmo T Laitinen
Cellular and Molecular Neurobiology|June 5, 2004
Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retinaJuha R Savinainen, Jarmo T Laitinen
Journal of Pineal Research|September 7, 2007
Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulationTarja Kokkola, Maija Vaittinen, Jarmo T Laitinen
British Journal of Pharmacology|January 18, 2006
The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sectionsVille A B Palomäki, Jarmo T Laitinen
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 13, 2010
Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometryNiina Aaltonen, Jarmo T Laitinen, Marko Lehtonen
British Journal of Pharmacology|January 13, 2006
The 'allosteric modulator' SCH-202676 disrupts G protein-coupled receptor function via sulphydryl-sensitive mechanismsAnna M Lewandowicz, Jouko Vepsäläinen, Jarmo T Laitinen
Neuropharmacology|June 20, 2003
2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12Kati S Vasiljev, Asko Uri, Jarmo T Laitinen
Journal of Radiation Research|October 8, 2005
Exposure to a 50-hz magnetic field induces a circadian rhythm in 6-hydroxymelatonin sulfate excretion in miceTimo Kumlin, Päivi Heikkinen, Jarmo T Laitinen, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD6Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
A Sensitive and Versatile Fluorescent Activity Assay for ABHD12Juha R Savinainen, Dina Navia-Paldanius, Jarmo T Laitinen
Pageof 6